INSP
Inspire Medical Systems, Inc. · $50.21 (+0.4%) · mkt cap $1.4B · P/E 11.4
1 hub catalysts across 1 sources · backtest → · ← Ticker Explorer
FDA Approvals & Recalls
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
25▲ Bullishconviction from hub signals
Bullish factors
- FDA approval
- 4 analyst upgrades
Bearish factors
- 7 analyst downgrades
- Insiders net selling (12 vs 1)
Best strategy
2-yr backtest · by SharpeGolden / Death Cross (50/200) has fit INSP best over 2 years (+63.3%, Sharpe 0.73). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Golden / Death Cross (50/200) | +63.3% | 0.73 | ✓ |
| 2 | SMA Crossover | +59.0% | 0.68 | ✓ |
| 3 | Triple MA (5/20/60) | +42.3% | 0.59 | ✓ |
Price — 1 year
daily closeInsider activity
1 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-05-15 | SELL | Rondoni John | 2,641 | $114K |
| 2026-05-14 | SELL | Rondoni John | 700 | $30K |
| 2026-05-08 | SELL | Mccormick Shawn T | 696 | $32K |
| 2026-01-09 | SELL | Rondoni John | 109 | $11K |
| 2025-12-02 | SELL | Mccormick Shawn T | 1,200 | $167K |
| 2025-11-28 | SELL | Mccormick Shawn T | 2,000 | $255K |
| 2025-08-29 | SELL | Buchholz Richard | 11,000 | $1.0M |
| 2025-08-08 | SELL | Curet Mcadams Myriam J | 6 | $616 |
| 2025-05-19 | SELL | Rondoni John | 1,734 | $259K |
| 2025-05-02 | SELL | Mccormick Shawn T | 360 | $58K |
| 2025-04-07 | BUY | Curet Mcadams Myriam J | 5 | $804 |
| 2025-03-03 | SELL | Rondoni John | 2,287 | $424K |
| 2025-03-03 | SELL | Ban Randall | 3,947 | $733K |
Analyst ratings
live · 12 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-01 | Initiated | Freedom Capital Markets | Buy |
| 2026-06-23 | Downgrade | Evercore ISI Group | Outperform → In-Line |
| 2026-05-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2026-02-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal-Weight |
| 2026-02-12 | Downgrade | Baird | Outperform → Neutral |
| 2026-01-27 | Downgrade | RBC Capital | Outperform → Sector Perform |
| 2025-12-08 | Upgrade | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Upgrade | Truist Securities | Hold → Buy |
| 2025-11-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Upgrade | Stifel | Hold → Buy |
Catalyst timeline
1 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | FDA Approvals & Recalls | FDA Approval | FDA approved Model 3150 Implantable Pulse Generator (IPG) — Inspire Medical Systems | approval | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-07-22 11:15 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice